Authors:
- Traces the evolution of the Chinese Healthcare System
- Examines the medication market in China
- Sheds light on violence in healthcare
- Defines digital healthcare
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (10 chapters)
-
Front Matter
-
Back Matter
About this book
How efficient is the Chinese healthcare system? Milcent examines the medication market in China against the global picture of healthcare organization, and how public healthcare insurance plans have been implemented in recent years, as well as reforms to tackle hospital inefficiency. Healthcare reforms, demographic changes and an increase in wealth inequity have altered healthcare preferences, which need to be addressed. Significantly, the patient–medical staff relationship is analysed, with new proposals for different lines of communication. Milcent puts forward digital healthcare in China as a tool to solve inefficiency and rising tensions, and generate profit. Where China is leading in the digitalization of healthcare, other countries can learn important lessons. Chinese social models are also put into context with respect to current reforms and experimentation.
Authors and Affiliations
-
CNRS and Paris School of Economics (PSE), Paris, France
Carine Milcent
About the author
Bibliographic Information
Book Title: Healthcare Reform in China
Book Subtitle: From Violence To Digital Healthcare
Authors: Carine Milcent
DOI: https://doi.org/10.1007/978-3-319-69736-9
Publisher: Palgrave Pivot Cham
eBook Packages: Economics and Finance, Economics and Finance (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s) 2018
Hardcover ISBN: 978-3-319-69735-2Published: 23 February 2018
eBook ISBN: 978-3-319-69736-9Published: 14 February 2018
Edition Number: 1
Number of Pages: XV, 250
Number of Illustrations: 3 b/w illustrations, 18 illustrations in colour
Topics: Health Economics, Public Health, R & D/Technology Policy, Asian Economics